NEXENTIS TECHNOLOGIES INC. Employee Benefits and Share-based Compensation
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Employee Benefits and Share-based Compensation of $70.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2026-06-30 was $70.00K, a 6900.00% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2026-03-31 was $90.00K, a 8900.00% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $1.00K.
- NEXENTIS TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2025-06-30 was $1.00K.
- NEXENTIS TECHNOLOGIES INC. employee benefits and share-based compensation for fiscal 2023 was $48.00K.
| Period end | Employee Benefits and Share-based Compensation 0 month | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $70.00K 10-Q · filed 2026-08-13 | $160.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $90.00K 10-Q · filed 2026-05-14 | ||||
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-13 | $2.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.00K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-14 | $1.00K 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-14 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $29.84K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $29.84K derived: sum of 3 quarters · filed 2025-08-14 | $33.75K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $29.84K derived: sum of 2 quarters · filed 2025-03-31 | $33.75K derived: sum of 3 quarters · filed 2025-03-31 | $39.54K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-12-31 | $29.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $33.75K derived: sum of 2 quarters · filed 2025-03-31 | $39.54K derived: sum of 3 quarters · filed 2025-03-31 | $48.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $3.92K 10-Q · filed 2024-11-14 | $9.70K derived: sum of 2 quarters · filed 2024-11-14 | $18.16K 10-Q · filed 2024-11-14 | ||
| 2023-08-07 | $173.99K 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $5.79K 10-Q · filed 2024-08-14 | $14.25K 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $8.46K 10-Q · filed 2024-05-15 | ||||
| 2022-03-31 | $11.82K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |